Alle kliniske isolater blev hæmmet ved retapamulinkoncentrationer på ≤ 2µg/ ml.
5 No development of resistance was observed during treatment with retapamulin in the clinical study programme and all clinical isolates were inhibited by retapamulin concentrations of < 2µg/ ml.